|
News

Customer
Stories

About
Us

Contacts

|
Assisting cGMP
Expansion at PCAS
PCAS (Paris, France) a leader in fine
and specialty chemicals selects STARLIMS for its
Villeneuve-la-Garenne (VLG-CHEM) cGMP site operated in cooperation
with Aventis In June 2004, PCAS acquired 85% of the VLG CHEM stock,
Aventis keeping 15% of its ownership. This agreement has been
concluded in accordance with the agenda announced
last January and is part of the Aventis-PCAS cooperation. It will
allow preserving activity and employment with an optimized
utilization of both partners' production capacities including those
of the Villeneuve-la-Garenne plant. Aventis will continue to have
certain products manufactured by VLG CHEM in the frame of long term
industrial agreements and will transfer to VLG CHEM various toll
manufacturing agreements concluded with third parties. In addition
PCAS plans to transfer to Villeneuve-la-Garenne some strategical
activities which will also contribute to the development of this
site.
PCAS products include
molecules and active ingredients designed to meet specific
characteristics and performance criteria defined by or in
partnership with customers. PCAS is supported by extensive R&D
capabilities and flexible and polyvalent production facilities.
STARLIMS has been supporting PCAS’ growth in cGMP manufacturing
since 1992 when it was implemented at PCAS production sites in Limay
(PCAS-SELOC). In 2003 PCAS expanded the STARLIMS implementation to
support its second site located in Aramon (Expanisa) will now be
implemented at VLG-CHEM. All three sites operate under cGMP
standards in compliance with FDA requirements.
The PCAS Group markets its products to five global target markets:
pharmaceutical synthesis and dosage forms, aroma
chemicals-cosmetics, photochemistry and new technologies, industrial
specialty chemicals and fine inorganic chemistry. In each of these
markets, PCAS has expertise in technologies, key processes and
regulatory compliance. This enables PCAS to intervene in all stages
of the design, production and commercial introduction of active
molecules.
|
|